200HO02713 ALCHEMY *RC

Print/PDF
Registration Name HUNSBERGER ALCHEMY-ET
Registration Number HOUSA000069080973
Primary NAAB Code 200HO02713
Secondary Code(s)
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 6/22/2010
aAa -
DMS -
GFI 6.8%
Genetic Codes * RC TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-C, HHR-C
Sire SCIENTIFIC DESTRY-ET
MGS PICSTON SHOTTLE-ET
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ -481, 93% R CM$ -474
NM Percentile 07% FM$ -494
GTPI 2091 GM$ -516
PRODUCTION TRAITS
3207 Dtrs 1579 herds 42 % US 99% R
Milk -524 Fat, % -53 , -0.12%
SCS 2.77, 99% R Protein, % -14 , +0.01%
Feed Saved -377 , 68% R Milking Speed 7.25 , 70% R
Health & Fertility
Productive Life 0.2      98% R Mastitis 1.4      95% R
Heifer Livability -0.3       81% R Metritis 0.0      88% R
Livability -0.5      95% R D. Abom -1.1      92% R
DPR 0.7      99% R Ketosis 0.6      86% R
FSC -3.9      99% R R. Placenta 1.5      89% R
HCR -0.1      95% R Milk Fever 0.0      80% R
CCR -0.4      99% R
SCR -        -
DIA -0.3      52% R
RSP -0.6      67% R
Calving Traits
Sire CE 1.7      98% R 4796 Obs
Daughter CE 2.4      98% R 1753 Obs, 2318 Dtrs
Sire SB 4.6      97% R 4599 Obs
Daughter SB 6.5      97% R 1544 Obs, Dtrs
Gestation Length 3.3      99% R 332 Obs, 1898 Dtrs
Early First Calving -1.3      97% R 425 Obs, 1143 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1735 Dtrs 978 herds 99% R
PTA Type -0.13 UDC -0.50
HCC -1.60 BWC 0.82
FLC -1.52
Linear Traits
Stature 0.59
Tall
Strength 0.39
Strong
Body Depth 0.56
Deep
Dairy Form -0.64
Closed
Rump Angle -0.89
Flat
Thurl Width 0.35
Flat
Rear Legs-Side View 0.35
Wide
Rear Legs-Rear View -1.73
H.-in
Foot Angle -1.04
Low
Feet & Legs Score -1.02
Low
F.U. Attachment 2.55
Curved
Rear Udder Height -1.28
Low
Rear Udder Width -2.68
Narrow
Udder Cleft 0.11
Strong
Udder Depth -1.73
H.-in
Front Teat Placement 0.81
Close
Rear Teat Placement 0.87
Close
Teat Length 0.62
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO